- Abstract Number: 1913
B Cell Depletion Therapy Impact CD8 T Cells in ANCA-Associated Vasculitis
- Abstract Number: 2117
B Cell Phenotype and in Vitro Function in Patients with Rheumatoid Arthritis Developing Low Serum Immunoglobulins after Multiple Cycles of Rituximab
- Abstract Number: 917
B Cells Inhibit Osteoblast Differentiation in Inflammatory Arthritis
- Abstract Number: 2873
B-Cell activating Factor Genetic Variants in Systemic Lupus Erythematosus and Lupus Related Atherosclerosis
- Abstract Number: 1080
B-Cell Clonal Expansions in Parotid Glands of Sjogren’s Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes
- Abstract Number: 2772
Back Pain in Psoriatic Arthritis: Defining Prevalence, Characteristics and Performance of the Different Inflammatory Back Pain Criteria in a Psoriatic Arthritis Cohort
- Abstract Number: 1417
Back to Feeling Normal Again: Patients with Rheumatoid Arthritis in Remission
- Abstract Number: 2710
Bacterial Dysbiosis Associates with Functional Intraepithelial Lymphocyte Changes in Inflammatory Bowel Disease and Spondyloarthritis
- Abstract Number: 1076
BAFF Receptor Antagonists Suppress Differentiation of B Cells in Vitro and Are Drug Candidates for Primary SjöGren’s Syndrome
- Abstract Number: 844
Bardoxolone Methyl Produces Durable Benefits in Participants with Pulmonary Arterial Hypertension: Data from an Open-Label Extension Study
- Abstract Number: 1584
Bari-00074565
- Abstract Number: 1593
Baricitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- Abstract Number: 2959
Baseline Endothelial Dysfunction Might Predict Immunosuppressive Need in Young, Male Behcet’s Patients with Early Disease: A Prospective Follow-up
- Abstract Number: 1702
Baseline Patient Characteristics Associated with Response to Biologic Therapy in Patients with Psoriatic Arthritis Enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
- Abstract Number: 28
Baseline Serum Inflammatory Biomarkers at Cohort Entry in 1974 Predicted Cardiovascular Disease (CVD) Mortality from 1995 through 2015 in a Prospective, Community-Based Study of Incident Rheumatoid Arthritis (RA) Patients and Matched Non-RA (CN) Subjects
- Abstract Number: 1652
Basement Membrane Remodeling Is Significantly Increased with Rheumatoid Arthritis and Suppressed By IL6 Inhibition: Analysis of Two Phase III Clinical Trial
- Abstract Number: 811
Basophils Are Activated and Stimulate Both B Cells and Fibroblasts in Systemic Sclerosis
- Abstract Number: 2940
Bechet’s Disease and Sleep Quality in Korean Patients
- Abstract Number: 508
Before Clinically Detectable Arthritis Develops, ACPA-Positive and ACPA-Negative Arthralgia Patients Have Different Symptoms
- Abstract Number: 2963
BehçEt’s Disease in Children: Eastern Mediterranean Experience
- Abstract Number: 780
Belimumab Use in African-American Patients in an U.S. Academic Medical Center
- Abstract Number: 1681
Beneficial Effect of n-3 Polyunsaturated Fatty Acids on Inflammation and Analgesic Use in Psoriatic Arthritis – a Randomised, Double Blind, Placebo-Controlled Trial
- Abstract Number: 12
Benefit of Early Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid Arthritis and Undifferentiated Early Arthritis (CONAART)
- Abstract Number: 2779
Better Health-Related Quality of Life and Work Capacity in Patients Achieving Inactive Disease and Clinical Response in Patients with Non-Radiographic Axial Spondyloarthritis
- Abstract Number: 1005
Biallelic Hypomorphic Mutations in a Linear Deubiquitinase Define Otulipenia, an Early-Onset Systemic Autoinflammatory Disease
- Abstract Number: 2013
BIIB059, a Monoclonal Antibody Targeting BDCA2, Shows Evidence of Biological Activity and Early Clinical Proof of Concept in Subjects with Active Cutaneous SLE
- Abstract Number: 774
BIIB059, an Anti-BDCA2 Monoclonal Antibody, Demonstrates Acceptable Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects in a Phase 1 Study with Single Ascending Doses (SAD) in Healthy Volunteers
- Abstract Number: 2060
Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses
- Abstract Number: 2994
Binding of Periostin to Discoidin Domain Receptor-1 (DDR1) Promotes Cartilage Degeneration By Inducing MMP-13 Expression
- Abstract Number: 331
Biologic Disease-Modifying Anti-Rheumatic Drug Use and the Risk of Non-Vertebral Osteoporotic Fractures in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study
- Abstract Number: 2237
Biologic DMARD Use Among U.S. Patients in an Online Rheumatoid Arthritis Community
- Abstract Number: 631
Biologic Free Remission Rate with Etanercept in Rheumatoid Arthritis: A Potential Role of Gender
- Abstract Number: 637
Biologic Initiation Patterns Among Rheumatoid Arthritis Patients in Moderate or High Disease Activity While Using Conventional Disease Modifying Anti-Rheumatic Drugs
- Abstract Number: 2955
Biologic Therapy in Severe Peripheral Ulcerative Keratitis (PUK). Multicenter Study of 27 Patients
- Abstract Number: 2375
Biologic Therapy Modifies Clinical and Laboratory Features of Macrophage Activation Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 2669
Biological Treatments in Primary SjöGren Syndrome
- Abstract Number: 799
Biomarker Identification & Molecular Sub-Classification in Systemic Sclerosis for Precision Medicine Using RNA-Seq
- Abstract Number: 1492
Biomarker-Related Risk for Myocardial Infarction and Serious Infections in Patients with Rheumatoid Arthritis: A Population-Based Study
- Abstract Number: 2286
Bioresponsive Glucocorticoid-Loaded Microparticles to Prevent Acute Gout Flares
- Abstract Number: 19L
Biosimilar Infliximab (CT-P13) Is Not Inferior to Originator Infliximab: Results from a 52-Week Randomized Switch Trial in Norway
- Abstract Number: 2436
Birth Outcomes Significantly Worsen after the Development of Systemic Lupus Erythematosus in a Population-Based Registry
- Abstract Number: 348
Bisphosphonates-Related Atypical Femur Fractures: 8 Years’ Experience in a Single Center
- Abstract Number: 2064
Blood and Kidney Molecular Profiles Distinguish Subjects with Lupus Nephritis from Other Kidney Disorders
- Abstract Number: 11L
BMS-986165 Is a Highly Potent and Selective Allosteric Inhibitor of Tyk2, Blocks IL-12, IL-23 and Type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Systemic Lupus Erythematosus and Inflammatory Bowel Disease
- Abstract Number: 3204
Body Composition and Adipose Tissue Distribution in Juvenile Dermatomyositis and Associations with Cardiac Function
- Abstract Number: 1583
Body Mass Index Does Not Affect Response to Subcutaneous or Intravenous Abatacept in Patients with Rheumatoid Arthritis
- Abstract Number: 1589
Body Mass Index Does Not Impact Abatacept Retention in Biologic-Naive Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: A 12-Month Interim Analysis of an Observational, Prospective Study
- Abstract Number: 548
Body Mass Index Is Positively Correlated with Diverse Disease Activity Measures in Longstanding Rheumatoid Arthritis
- Abstract Number: 1105
Bone Metabolism in Rheumatic Diseases May be Affected By Free Fatty Acids
- Abstract Number: 167
Bone Mineral Density Loss in Clinically Suspect Arthralgia Is Associated with Subclinical Inflammation and Progression to Clinical Arthritis
- Abstract Number: 3229
Bone Morphogenetic Protein 6 Receptor Inhibition Restores Salivary Gland Function in a Mouse Model of Primary Sjögren’s Syndrome
- Abstract Number: 2134
Bone Replaces Cartilage in Non-Weight Bearing Regions of Immobilized Knees
- Abstract Number: 1512
Bone Structural Deficits in Rheumatoid Arthritis: Impact of Muscle Mass and Density
- Abstract Number: 546
Boolean-Based Remission in Rheumatoid Arthritis Using Physician Versus Patient Global Assessment: Differences in Ultrasonographic Disease Activities, Sustainabilities, and Relapse Rates
- Abstract Number: 2787
Bortezomib Treatment Induces Higher Mortality Rate in Lupus Model Mice with High Disease Activity
- Abstract Number: 2782
Bortezomib Treatment Prevents Glomerulosclerosis Associated with Lupus Nephritis in a Murine Model through Suppressive Effects on the Immune and Renin-Angiotensin Systems
- Abstract Number: 998
Brain Responses to Other’s Pain in Fibromyalgia – a Magnetoencephalography (MEG) Study
- Abstract Number: 3139
Breaking the Cycle: Analyzing Preventable Hospital Admissions Due to Gout
- Abstract Number: 2816
Broad Autoantibody Profiling in Ethnically Diverse SLE Cohorts Reveals a Set of Conserved Autoantibodies That Are Correlated to a Type I Interferon Signature
- Abstract Number: 3217
Broad-Based Interrogation of the Serum Proteome Suggests That RA Onset Is Associated with Activation of the Intrinsic Coagulation Cascade
- Abstract Number: 1938
Bronchiectasis Are Highly Prevalent in Anti-MPO ANCA-Associated Vasculitis and Associate with a Distinct Disease Phenotype
2016 ACR/ARHP Annual Meeting
November 11-16, 2016. Washington, DC.